Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Etoposide. Current and future status.

J Aisner1, E J Lee

  • 1University of Maryland Cancer Center, Baltimore 21201.

Cancer
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Etoposide (VP-16-213) is a vital chemotherapy drug effective against various cancers. Research indicates that optimizing etoposide

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabolic acidosis as a risk factor for bronchopulmonary dysplasia in preterm infants born between 23 + 0 and 31 + 6 weeks of gestation: a retrospective case-control study.

Frontiers in pediatrics·2025
Same author

Menopause and its effects on autonomic regulation of blood pressure: Insights and perspectives.

Autonomic neuroscience : basic & clinical·2025
Same author

Ameliorating effect of 2'-fucosyllactose and 6'-sialyllactose on lipopolysaccharide-induced intestinal inflammation.

Journal of dairy science·2024
Same author

Pathological Prescribing: "A Science Falsely So-called".

The Homoeopathic physician·2023
Same author

Specifics.

The Homoeopathic physician·2023
Same author

Lachesis and Lycopodium in Diphtheria.

The Homoeopathic physician·2023
Same journal

Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

Cancer·2026
Same journal

Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

Cancer·2026
Same journal

EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

Cancer·2026
Same journal

Nivolumab and chemotherapy combination approved for previously untreated Hodgkin lymphoma.

Cancer·2026
Same journal

Most older patients with advanced cancer prioritize QOL over extending survival: A secondary analysis of the GAP70+ trial found that among adults aged 70 and older with advanced, noncurable cancer, nearly three-quarters prioritized maintaining QOL.

Cancer·2026
Same journal

Real-world safety, prognostic, and design considerations in ketogenic diet trials for pancreatic cancer.

Cancer·2026
See all related articles

Area of Science:

  • Oncology
  • Pharmacology

Background:

  • Etoposide (VP-16-213) is a key antineoplastic agent.
  • It demonstrates efficacy across a wide range of human malignancies.

Purpose of the Study:

  • To highlight the importance of etoposide in cancer therapy.
  • To emphasize the impact of dose and schedule on treatment outcomes.

Main Methods:

  • Review of existing clinical studies and preclinical models.
  • Analysis of etoposide's synergistic effects in combination chemotherapy.

Main Results:

  • Etoposide is a standard therapy for testicular and small cell lung cancer.
  • Its efficacy extends to lymphomas, leukemias, and solid tumors.
  • Dose and exposure time significantly influence cellular kill and tumor response.

Related Experiment Videos

Conclusions:

  • Further research is warranted to optimize etoposide's use.
  • Investigating higher doses and prolonged schedules may enhance its potential.
  • Etoposide's role in initial cancer therapy requires continued exploration.